Company: TVRD
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001104659-25-097519
Chunk: 351

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-07
Form: S-1/A
Chunk 351
---
 |
| Weighted-average discount rate        |   |                                9.50 | % | 9.50 | % |   |                              9.50 | % | 9.50 | % |
| Weighted-average remaining lease term |   |                                2.08 |   | 3.08 | ​ |   |                              2.08 |   | 3.08 | ​ |

As of June 30, 2025, the maturities of the Company’s operating lease liabilities were as follows (in thousands):

| ​                                                   
 Year Ended December 31,                             
 2025 (remaining six months)                         | ​ 
 ​ | ​      
 Amount |   ​ 
  64 |
|:----------------------------------------------------|:--|:-------|----:|
| 2026                                                | ​ |        | 129 |
| 2027                                                | ​ |        |  88 |
| Total lease payments                                | ​ |        | 281 |
| Less: imputed interest                              | ​ |        | -27 |
| Present value of lease liabilities                  | ​ |        | 254 |
| Less: operating lease liabilities, current portion  | ​ | $      | 109 |
| Operating lease liabilities, net of current portion | ​ | $      | 145 |

9.Stockholders’ Equity (Deficit)

Redeemable Convertible Preferred Stock

Prior to the conversion upon the closing of the Merger, Legacy Tvardi issued Series A preferred stock and Series B preferred stock (the Preferred Stock). Prior to the completion of the Merger, Legacy Tvardi classified the Preferred Stock outside of permanent equity as the shares had redemption features that were not entirely within the control of Legacy Tvardi. As discussed in Note 3,Merger Agreement, upon the closing of the Merger, Legacy Tvardi’s Preferred Stock converted into3,963,910shares of the Company’s common stock.

Preferred Stock

As of June 30, 2025, the Company had5,000,000shares of preferred stock authorized,$ 0.001par value, pursuant to its amended and restated certificate of incorporation. However,nosuch shares were issued oroutstandingas of June 30, 2025.

Common Stock

As discussed in Note 3,Merger Agreement, the Company completed its Merger with Cara in April 2025. Upon the closing of the Merger, the following shares of common stock were received by Legacy